About
Gritstone Bio develops immunotherapies that use multi-specific antibodies to target tumor cells by recognizing unique HLA-peptide complexes, aiming to stimulate durable immune responses in cancer patients.
Explore Gritstone Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.